Elizabeth Krieger, MD

Dr. Krieger is a pediatric hematologist-oncologist specializing in bone marrow transplant and cellular therapies. She returns to VCU from the University of Minnesota where she trained with leading experts in the field of bone marrow transplant and cellular therapies for rare conditions including Fanconi's anemia, metabolic disorders, adrenal leukodystrophy, immunodeficiency and cellular therapies. Dr. Krieger is an active member of the American Society of Transplantation and Cellular Therapies and sits on the National Marrow Donor Program Histocompatibility
Advisory Group KIR Working Group.

• E Krieger, R. Qayyum, A. Keating, A Toor. Inhibitory KIR-Ligand Interactions and Relapse Protection Following HLA Matched Allogeneic HCT for AML. BMT. July 2021. DOI: 10.1038/s41409-021-01393-9
• E Krieger, A Toor. Can GVL be uncoupled from GVHD? An Examination of Proportions. Fron. Immunol. April 2020. 11:777. DOI: 10.3389/fimmu.2020.00777
• E. Krieger, R. Sabo, S. Moezzi, C. Cain, C. Roberts, P. Kimball, A. Chesney, J. McCarty, A. Keating, R. Romee, C. Wiedl, R. Qayyum, A. Toor. Killer Immunoglobulin-like Receptor-Ligand Interactions Predict Clinical Outcomes Following Unrelated Donor Transplants. Biol Blood Marrow Transplant. 2020 Apr;26(4):672-682. DOI:10.1016/j.bbmt.2019.10.016